耐他唑巴坦/哌拉西林维龙菌引起的褥疮感染和菌血症。

IF 0.9 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Nagoya Journal of Medical Science Pub Date : 2024-08-01 DOI:10.18999/nagjms.86.3.524
Shoko Sahara, Teruhisa Kinoshita, Tomomi Amano, Misa Ishida, Takashi Yamakita, Norio Takimoto, Keisuke Oka
{"title":"耐他唑巴坦/哌拉西林维龙菌引起的褥疮感染和菌血症。","authors":"Shoko Sahara, Teruhisa Kinoshita, Tomomi Amano, Misa Ishida, Takashi Yamakita, Norio Takimoto, Keisuke Oka","doi":"10.18999/nagjms.86.3.524","DOIUrl":null,"url":null,"abstract":"<p><p>This is the first case report of decubitus infection and bacteremia due to <i>Veillonella parvula</i> (<i>V. parvula</i>). A patient in his 70s with pre-existing diabetes mellitus was admitted with decubitus infection, and tazobactam/piperacillin treatment was initiated. Tazobactam/piperacillin-resistant <i>V. parvula</i> was detected in the blood and decubitus site cultures. The antimicrobial treatment was changed to clindamycin and cefmetazole. Antimicrobial therapy was administered for 28 days. The patient was transferred to a convalescent hospital. <i>V. parvula</i> occasionally causes infection in immunocompromised patients with underlying diseases, such as diabetes. An appropriate evaluation by culture test is important for diagnosis, treatment, and recurrence prevention. Tazobactam/piperacillin is often used in the treatment of multi-bacterial infections such as decubitus infections. <i>V. parvula</i> may be resistant to tazobactam/piperacillin, and this possibility should be taken into account when administering treatment.</p>","PeriodicalId":49014,"journal":{"name":"Nagoya Journal of Medical Science","volume":"86 3","pages":"524-530"},"PeriodicalIF":0.9000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11439600/pdf/","citationCount":"0","resultStr":"{\"title\":\"Decubitus ulcer infection and bacteremia due to tazobactam/piperacillin-resistant <i>Veillonella parvula</i>.\",\"authors\":\"Shoko Sahara, Teruhisa Kinoshita, Tomomi Amano, Misa Ishida, Takashi Yamakita, Norio Takimoto, Keisuke Oka\",\"doi\":\"10.18999/nagjms.86.3.524\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>This is the first case report of decubitus infection and bacteremia due to <i>Veillonella parvula</i> (<i>V. parvula</i>). A patient in his 70s with pre-existing diabetes mellitus was admitted with decubitus infection, and tazobactam/piperacillin treatment was initiated. Tazobactam/piperacillin-resistant <i>V. parvula</i> was detected in the blood and decubitus site cultures. The antimicrobial treatment was changed to clindamycin and cefmetazole. Antimicrobial therapy was administered for 28 days. The patient was transferred to a convalescent hospital. <i>V. parvula</i> occasionally causes infection in immunocompromised patients with underlying diseases, such as diabetes. An appropriate evaluation by culture test is important for diagnosis, treatment, and recurrence prevention. Tazobactam/piperacillin is often used in the treatment of multi-bacterial infections such as decubitus infections. <i>V. parvula</i> may be resistant to tazobactam/piperacillin, and this possibility should be taken into account when administering treatment.</p>\",\"PeriodicalId\":49014,\"journal\":{\"name\":\"Nagoya Journal of Medical Science\",\"volume\":\"86 3\",\"pages\":\"524-530\"},\"PeriodicalIF\":0.9000,\"publicationDate\":\"2024-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11439600/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nagoya Journal of Medical Science\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.18999/nagjms.86.3.524\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nagoya Journal of Medical Science","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.18999/nagjms.86.3.524","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

摘要

这是首例褥疮感染和副褥疮威洛菌(V. Veillonella parvula)菌血症的病例报告。一名 70 多岁的患者因褥疮感染入院,开始接受他唑巴坦/哌拉西林治疗。在血液和褥疮部位的培养物中检测到了耐他唑巴坦/哌拉西林的伞菌。抗菌治疗改为克林霉素和头孢美唑。抗菌治疗持续了 28 天。患者被转到一家疗养医院。伴有糖尿病等基础疾病的免疫力低下患者偶尔会感染副猪弧菌。通过培养试验进行适当的评估对于诊断、治疗和预防复发非常重要。他唑巴坦/哌拉西林常用于治疗多种细菌感染,如褥疮感染。伞菌可能对他唑巴坦/哌拉西林产生耐药性,因此在治疗时应考虑到这种可能性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Decubitus ulcer infection and bacteremia due to tazobactam/piperacillin-resistant Veillonella parvula.

This is the first case report of decubitus infection and bacteremia due to Veillonella parvula (V. parvula). A patient in his 70s with pre-existing diabetes mellitus was admitted with decubitus infection, and tazobactam/piperacillin treatment was initiated. Tazobactam/piperacillin-resistant V. parvula was detected in the blood and decubitus site cultures. The antimicrobial treatment was changed to clindamycin and cefmetazole. Antimicrobial therapy was administered for 28 days. The patient was transferred to a convalescent hospital. V. parvula occasionally causes infection in immunocompromised patients with underlying diseases, such as diabetes. An appropriate evaluation by culture test is important for diagnosis, treatment, and recurrence prevention. Tazobactam/piperacillin is often used in the treatment of multi-bacterial infections such as decubitus infections. V. parvula may be resistant to tazobactam/piperacillin, and this possibility should be taken into account when administering treatment.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Nagoya Journal of Medical Science
Nagoya Journal of Medical Science MEDICINE, RESEARCH & EXPERIMENTAL-
CiteScore
1.30
自引率
0.00%
发文量
65
审稿时长
>12 weeks
期刊介绍: The Journal publishes original papers in the areas of medical science and its related fields. Reviews, symposium reports, short communications, notes, case reports, hypothesis papers, medical image at a glance, video and announcements are also accepted. Manuscripts should be in English. It is recommended that an English check of the manuscript by a competent and knowledgeable native speaker be completed before submission.
期刊最新文献
A novel technique for C1-C2 posterior screw insertion using patient-specific guides created by CT-based 3D printing. Adenosine triphosphate release inhibitors targeting pannexin1 improve recovery after spinal cord injury. Appendiceal adenocarcinoma associated with Amyand's hernia: a case report. Crucial roles of exosomes secreted from ganglioside GD3/GD2-positive glioma cells in enhancement of the malignant phenotypes and signals of GD3/GD2-negative glioma cells. Decubitus ulcer infection and bacteremia due to tazobactam/piperacillin-resistant Veillonella parvula.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1